Morsef Pharmaceuticals Private Limited, a active private limited company, was established on 04 June 1999 in Mumbai, Maharashtra, India. Engaging in industrial machinery retail & distribution within the trade sector, it holds CIN: U51900MH1999PTC120206. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.10 M.
Formerly known as Cibien International Private Limited. It upholds a compliant status. Its leadership includes Atul Vasudeo Bhopale (Director), Shilpa H Bhatt (Director), Himanshu Rajnikant Bhatt (Manager). Past directors included Anil Mohanlal Narang, Himanshu Rajnikant Bhatt, Nandlal Mohanlal Narang. It holds ₹7.00 M open charges and no settled loans. Its latest AGM occurred on 02 June 2025, with the balance sheet filed on 31 March 2025. It is based at 401 Bhaveshwar Complexopp Vidyavihar Railway Station, Mumbai, Maharashtra, 400086.
U51900MH1999PTC120206
120206
04 June 1999
₹5.00 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Morsef Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Atul Vasudeo Bhopale | Director | 29 May 2024 | Current |
| Shilpa H Bhatt | Director | 27 Jun 2012 | Current |
| Himanshu Rajnikant Bhatt | Manager | 04 Jun 1999 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Jan 2012 | Past |
| Pramod Abcsdd | Manager | - | Past |
| Pramod Abcsdd | Additional Director | 21 Aug 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Morsef Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.1% increase. The company also saw a substantial improvement in profitability, with a 83.54% increase in profit. The company's net worth Soared by an impressive increase of 31.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Morsef Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹7,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Feb 2021 | Others | ₹7.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Morsef Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Morsef Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morsef Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Morsef Pharmaceuticals Private Limited last Annual general meeting of members was held on 02 Jun 2025 as per latest MCA records. was recorded as a recent event.
Progress on Morsef Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on Atul Vasudeo Bhopale was appointed as a Director was appointed as a Director on 29 May 2024 & has been associated with this company since 1 year 7 months . was documented.
Progress on A charge with Others amounted to Rs. 7.00 M with Charge ID 100421582 was registered on 08 Feb 2021. was documented.
The activity Shilpa H Bhatt was appointed as a Director was appointed as a Director on 27 Jun 2012 & has been associated with this company since 13 years 6 months . was completed.
Progress on Himanshu Rajnikant Bhatt was appointed as a Manager was appointed as a Manager on 04 Jun 1999 & has been associated with this company since 26 years 7 months . was documented.
The CIN of Morsef Pharmaceuticals Private Limited is U51900MH1999PTC120206.
Morsef Pharmaceuticals Private Limited is headquartered at 401 Bhaveshwar Complexopp Vidyavihar Railway Station, Mumbai, Maharashtra, 400086.
Morsef Pharmaceuticals Private Limited was incorporated on 04 June 1999.
The current directors of Morsef Pharmaceuticals Private Limited are
The primary industry of Morsef Pharmaceuticals Private Limited is Trade.
Morsef Pharmaceuticals Private Limited is unlisted.
The authorized capital of Morsef Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Morsef Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX